FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297254859> ?p ?o ?g. }

• W4297254859 endingPage "122208" @default.
• W4297254859 startingPage "122208" @default.
• W4297254859 abstract "Mortality rate of metastatic breast cancer is linked to cancer stem cells (CSCs)’ aggressive features (chemoresistance to apoptosis and redox imbalance). Therefore, unique dual therapeutic strategy compacts CSCs with inducing oxidative stress-mediated nonapoptosis (ferroptosis), confers effective malignant tumor eradication. Diethyldithiocarbamate (DDC) is a potent inhibitor of CSC aldehyde dehydrogenase and lowers glutathione (GSH) which aggravate iron-dependent ferroptosis. Herein, nanoformulations of DDC with green chemically synthesized ferrous oxide nanoparticles (FeO NPs) and ferric oxide (Fe2O3 NPs) were prepared. Due to nanoparticle characters and synergistic effect between iron oxide NPs and DDC, nanocomplexes (DFeO NPs and DFe2O3 NPs, respectively) exhibited the strongest anti-metastatic cancer potency in vitro. Because of corresponding iron oxide nature, DFeO NPs demonstrated better therapeutic efficacy than DFe4O3 NPs, in mammary tumor liver metastasis-bearing mice, in terms of tumor size, histological analysis, immunostaining % of ki-67+ and caspase 3+, and gene expression of p53 and BCl2. The potent anti-tumor effect of DFeO nanocomplex is attributed to the maximum elevation of reactive oxygen species and lipid peroxidation (ferroptosis hall marker) with severe depletion of GSH and Nrf2 selectively in both tumor tissues, causing CSC eradication with halting metastatic activity. The latters were confirmed by lowering CD44+ % and gene expression of HIF-α, β-catenin, Notch, ABCG2-mediated chemoresistance, and MMP9 with diminishing liver tumor marker. Moreover, this nanocomplex did not cause any abnormal alterations in histological and biochemical parameters, compared to healthy group. Therefore, the selective apoptotic and ferroptotic with anti-CSC effects of DFeO NPs open new safe avenue for metastatic tumor therapy." @default.
• W4297254859 created "2022-09-28" @default.
• W4297254859 creator A5048959445 @default.
• W4297254859 creator A5054611309 @default.
• W4297254859 date "2022-11-01" @default.
• W4297254859 modified "2023-10-01" @default.
• W4297254859 title "Anti-metastatic breast cancer potential of novel nanocomplexes of diethyldithiocarbamate and green chemically synthesized iron oxide nanoparticles" @default.
• W4297254859 cites W1868543250 @default.
• W4297254859 cites W1983236803 @default.
• W4297254859 cites W1983310681 @default.
• W4297254859 cites W2001372725 @default.
• W4297254859 cites W2006370393 @default.
• W4297254859 cites W2027554821 @default.
• W4297254859 cites W2046922897 @default.
• W4297254859 cites W2047758994 @default.
• W4297254859 cites W2113425926 @default.
• W4297254859 cites W2114918609 @default.
• W4297254859 cites W2117692326 @default.
• W4297254859 cites W2129612484 @default.
• W4297254859 cites W2144190812 @default.
• W4297254859 cites W2161103689 @default.
• W4297254859 cites W2177555958 @default.
• W4297254859 cites W2327686392 @default.
• W4297254859 cites W2336297584 @default.
• W4297254859 cites W2586840087 @default.
• W4297254859 cites W2736125704 @default.
• W4297254859 cites W2790213688 @default.
• W4297254859 cites W2899438745 @default.
• W4297254859 cites W3042163371 @default.
• W4297254859 cites W3089471337 @default.
• W4297254859 cites W3093493199 @default.
• W4297254859 cites W3097153985 @default.
• W4297254859 cites W3128646645 @default.
• W4297254859 cites W3193546399 @default.
• W4297254859 cites W3196748873 @default.
• W4297254859 cites W3199512300 @default.
• W4297254859 cites W4206688835 @default.
• W4297254859 doi "https://doi.org/10.1016/j.ijpharm.2022.122208" @default.
• W4297254859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36122615" @default.
• W4297254859 hasPublicationYear "2022" @default.
• W4297254859 type Work @default.
• W4297254859 citedByCount "7" @default.
• W4297254859 countsByYear W42972548592022 @default.
• W4297254859 countsByYear W42972548592023 @default.
• W4297254859 crossrefType "journal-article" @default.
• W4297254859 hasAuthorship W4297254859A5048959445 @default.
• W4297254859 hasAuthorship W4297254859A5054611309 @default.
• W4297254859 hasConcept C121608353 @default.
• W4297254859 hasConcept C126322002 @default.
• W4297254859 hasConcept C181199279 @default.
• W4297254859 hasConcept C185592680 @default.
• W4297254859 hasConcept C190283241 @default.
• W4297254859 hasConcept C202751555 @default.
• W4297254859 hasConcept C2775930923 @default.
• W4297254859 hasConcept C2776151105 @default.
• W4297254859 hasConcept C2779013556 @default.
• W4297254859 hasConcept C2780829032 @default.
• W4297254859 hasConcept C2780932548 @default.
• W4297254859 hasConcept C48349386 @default.
• W4297254859 hasConcept C502942594 @default.
• W4297254859 hasConcept C530470458 @default.
• W4297254859 hasConcept C538909803 @default.
• W4297254859 hasConcept C55427017 @default.
• W4297254859 hasConcept C55493867 @default.
• W4297254859 hasConcept C71924100 @default.
• W4297254859 hasConcept C96232424 @default.
• W4297254859 hasConcept C98274493 @default.
• W4297254859 hasConceptScore W4297254859C121608353 @default.
• W4297254859 hasConceptScore W4297254859C126322002 @default.
• W4297254859 hasConceptScore W4297254859C181199279 @default.
• W4297254859 hasConceptScore W4297254859C185592680 @default.
• W4297254859 hasConceptScore W4297254859C190283241 @default.
• W4297254859 hasConceptScore W4297254859C202751555 @default.
• W4297254859 hasConceptScore W4297254859C2775930923 @default.
• W4297254859 hasConceptScore W4297254859C2776151105 @default.
• W4297254859 hasConceptScore W4297254859C2779013556 @default.
• W4297254859 hasConceptScore W4297254859C2780829032 @default.
• W4297254859 hasConceptScore W4297254859C2780932548 @default.
• W4297254859 hasConceptScore W4297254859C48349386 @default.
• W4297254859 hasConceptScore W4297254859C502942594 @default.
• W4297254859 hasConceptScore W4297254859C530470458 @default.
• W4297254859 hasConceptScore W4297254859C538909803 @default.
• W4297254859 hasConceptScore W4297254859C55427017 @default.
• W4297254859 hasConceptScore W4297254859C55493867 @default.
• W4297254859 hasConceptScore W4297254859C71924100 @default.
• W4297254859 hasConceptScore W4297254859C96232424 @default.
• W4297254859 hasConceptScore W4297254859C98274493 @default.
• W4297254859 hasLocation W42972548591 @default.
• W4297254859 hasLocation W42972548592 @default.
• W4297254859 hasOpenAccess W4297254859 @default.
• W4297254859 hasPrimaryLocation W42972548591 @default.
• W4297254859 hasRelatedWork W1594524304 @default.
• W4297254859 hasRelatedWork W1992782534 @default.
• W4297254859 hasRelatedWork W2117687081 @default.
• W4297254859 hasRelatedWork W2343191660 @default.
• W4297254859 hasRelatedWork W2560113976 @default.
• W4297254859 hasRelatedWork W2601778356 @default.
• W4297254859 hasRelatedWork W2770652508 @default.

• next